Chronos Archive seal
The Human Record

Duke Kahanamoku

Case HR-ML050-TD · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
August 24, 1890 – January 22, 1968
Synthetic DOB
1890-08-24
Index visit
1957-03-16 at age 66
Synthetic MRN
HR-ML050-SYN-TD

Teaching objective: Heart failure with reduced ejection fraction from ischemic cardiomyopathy in a 66-year-old Native Hawaiian man, sheriff of Honolulu and a lifelong Olympic swimmer and surfer, five years after a heart attack. The episode covers breathlessness, ankle swelling and tiredness diagnosed by NT-proBNP and echocardiography (ejection fraction 30%); invasive coronary angiography for the ischemic cause; the four pillars of guideline-directed medical therapy under the 1953 AHA/ACC/HFSA guideline and the 1955 ACC decision pathway: changing lisinopril to sacubitril-valsartan with a 36-hour washout, changing metoprolol tartrate to carvedilol, empagliflozin and spironolactone, titrated every two weeks with potassium, magnesium and kidney checks; a loop diuretic adjusted to euvolemia; intravenous iron for iron deficiency; sick-day rules when vomiting and diarrhea raise potassium and creatinine; a missed laboratory check recorded honestly; the decision against a primary-prevention defibrillator when the ejection fraction rose from 30% to 38% after more than 90 days of therapy; sodium guidance without routine fluid restriction; cardiac rehabilitation adapted to an ocean athlete, with swimming and surfing safety; vaccinations; and culturally safe care for a Native Hawaiian patient, with his ʻohana involved as he chooses, his own healing practices respected, and attention to the higher and earlier burden of heart failure hospitalization among Native Hawaiians.

Historical timeline

DateEventClaims
August 24, 1890Born in Honolulu.CLM-0001, CLM-0002
1911Co-founds the Hui Nalu surf club.CLM-0004
1912Olympic champion in the 100-meter freestyle at Stockholm.CLM-0003
December 24, 1914Surfing exhibition at Freshwater Beach, Sydney.CLM-0004
1920Two Olympic gold medals at Antwerp.CLM-0003
1922Moves to Los Angeles and acts in films.CLM-0005
1934 (1932 in some sources)First elected sheriff of Honolulu.CLM-0006
August 2, 1940Marries Nadine Alexander in Kailua-Kona.CLM-0007
1952Heart attack.CLM-0009, CLM-0008
1956Official U.S. representative at the Melbourne Olympic Games.CLM-0014, CLM-0013
1962Cerebral blood clot; survives a brain operation.CLM-0010
January 22, 1968Dies of a heart attack in Honolulu.CLM-0011
January 27, 1968Beachboy funeral at Waikīkī.CLM-0012

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D Duke Kahanamoku was born on August 24, 1890, in Honolulu, at Haleʻākala, the Honolulu home of Princess Bernice Pauahi Bishop; he was named after his father, who had been named Duke for a visit of the Duke of Edinburgh to Hawaiʻi.
Anchors the true birth date and his Native Hawaiian heritage and home in Honolulu. One International Swimming Hall of Fame tribute implies an August 14 birthday through its arithmetic; the dated sources agree on August 24.
confirmed Duke Kahanamoku: biography and life timeline. American Masters supports
Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 supports
Duke Kahanamoku (athlete profile) supports
Duke Kahanamoku. Research Starters: History supports
HISTMED Master Roster v3 supports
D Olympedia gives his full name as Duke Paoa Kahino Makoe Hulikohoa Kahanamoku.
Used only for the alias. Other spellings of the middle names exist; the brief's spelling (Kahinu Mokoe Hulikohola) was not found in a source that could be fetched.
probable Duke Kahanamoku (athlete profile) supports
D He won the Olympic 100-meter freestyle in 1912 at Stockholm (with silver in the 4 x 200-meter relay) and again in 1920 at Antwerp (with gold in the relay), and silver in the 100-meter freestyle in 1924 at Paris: three gold and two silver medals.
Anchors his identity as a lifelong swimmer in the modern social history and the adapted exercise plan.
confirmed Duke Kahanamoku: biography and life timeline. American Masters supports
Duke Kahanamoku (athlete profile) supports
Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 supports
August 24: celebrate the birth of one of Hawaii's greatest sons and 1965 ISHOF Honoree, Duke Kahanamoku supports
D He co-founded the Hui Nalu surf club in 1911, introduced surfing to the Atlantic coast of the United States in 1914 and gave a surfing exhibition at Freshwater Beach in Sydney on December 24, 1914, widely regarded as a seminal event for surfing in Australia; he was inducted into the International Swimming Hall of Fame in 1965 and was the first inductee of the International Surfing Hall of Fame in 1966.
Anchors his identity as a surfer and waterman in the modern social history.
confirmed Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 supports
Duke Kahanamoku: biography and life timeline. American Masters supports
Duke Kahanamoku (athlete profile) supports
D From 1922 he lived in Los Angeles for years and found small roles in many Hollywood films.
History only.
confirmed Duke Kahanamoku: biography and life timeline. American Masters supports
D He was elected sheriff of Honolulu for 13 consecutive terms, from 1934 until the post was eliminated in 1960, after which he was named Hawaiʻi's "Ambassador of Aloha"; other sources date his first election to 1932 and his departure to 1961.
Anchors his occupation at the index date (1957). The Star-Advertiser and PBS give 1934 to 1960; Olympedia, the Encyclopedia of World Biography and EBSCO give 1932 to 1961. Either way he was sheriff in 1957.
probable Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 supports
Duke Kahanamoku: biography and life timeline. American Masters supports
Duke Kahanamoku (athlete profile) disputes
Kahanamoku, Duke. Encyclopedia of World Biography disputes
D He married Nadine Alexander on August 2, 1940, in Kailua-Kona.
Documented history only; his wife is not given any role, statement or health fact in the modern episode.
confirmed Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 supports
Duke Kahanamoku: biography and life timeline. American Masters supports
D He never drank alcohol or smoked and trained consistently.
Anchors the substance history in the modern social history.
confirmed Kahanamoku, Duke. Encyclopedia of World Biography supports
Duke Kahanamoku. Research Starters: History supports
D He had a heart attack in 1952 and suffered several heart attacks in his later years, continuing to swim and sail almost to the end of his life.
The documented anchor for the old myocardial infarction in the modern episode. The year 1952 rests on the Honolulu Star-Advertiser alone; EBSCO says he had several heart attacks without dates. A heart attack in 1955, named in the brief, was not found in any source read and is not used.
probable Luis C. Legacy of Hawaii's most beloved, honored athlete endures 50 years after his death. Honolulu Star-Advertiser, January 22, 2018 supports
Duke Kahanamoku. Research Starters: History supports
D In 1962 he had a cerebral blood clot and survived a brain operation.
Later history, after the modern episode. The Star-Advertiser names a cerebral blood clot in 1962 and EBSCO an undated brain operation; a 1962 wire report of an operation for a blood clot on the brain at Kaiser Hospital, found in a search, could not be fetched. No source read describes a tumor.
probable Luis C. Legacy of Hawaii's most beloved, honored athlete endures 50 years after his death. Honolulu Star-Advertiser, January 22, 2018 supports
Duke Kahanamoku. Research Starters: History supports
D On January 22, 1968, he collapsed with a heart attack at the Waikiki Yacht Club while working on his boat, was taken to Kaiser Foundation Hospital and died there, aged 77.
The cause of death, a heart attack, fits the long course of coronary disease taught in the modern episode.
confirmed Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 supports
Duke Kahanamoku: biography and life timeline. American Masters supports
Duke Kahanamoku. Research Starters: History supports
Duke Kahanamoku (athlete profile) supports
HISTMED Master Roster v3 supports
D On January 27, 1968, his ashes were scattered off Waikīkī in a beachboy funeral attended by thousands.
History after his death.
confirmed Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 supports
D He had no great personal wealth.
Anchors his modest means in the modern social history.
confirmed Luis C. Legacy of Hawaii's most beloved, honored athlete endures 50 years after his death. Honolulu Star-Advertiser, January 22, 2018 supports
D He was the official United States representative at the 1956 Melbourne Olympic Games.
Anchors his continuing role in sport at the index date.
confirmed Duke Kahanamoku: biography and life timeline. American Masters supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Breathlessness on exertion for six weeks (paddling out, walking uphill, finishing his morning swim), with ankle swelling by evening and tiredness, five years after a heart attack; cause to be determined resolved confirmed active
S Coronary artery disease with an old anterior myocardial infarction five years ago, treated with medicines; synthetic modern episode linked to the documented heart attack of 1883 active confirmed both_with_link CLM-0009
S Heart failure with reduced ejection fraction from ischemic cardiomyopathy (ejection fraction 30% with a thinned, akinetic anterior wall and apex), NYHA class III at diagnosis active confirmed active CLM-0009
S Iron deficiency without anemia (ferritin 62 ng/mL, transferrin saturation 16%) active confirmed active
S Viral gastroenteritis for two days, with volume depletion, potassium 5.5 mmol/L and a rise in creatinine on sacubitril-valsartan, spironolactone, empagliflozin and furosemide; settled with sick-day rules resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 1957-03-16 Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 2450 pg/mL (high)
Reference Below 125 pg/mL makes heart failure unlikely outside the hospital
http://loinc.org · 33762-6
S 1957-03-16 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1957-03-16 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1957-03-16 Creatinine [Mass/volume] in Serum or Plasma 1.02 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1957-03-16 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M 81 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1957-03-16 Glucose [Mass/volume] in Serum or Plasma 102 mg/dL (high)
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1957-03-16 Magnesium [Mass/volume] in Serum or Plasma 2 mg/dL
Reference 1.6-2.6 mg/dL
http://loinc.org · 19123-9
S 1957-03-16 Hemoglobin [Mass/volume] in Blood 13.4 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1957-03-16 Ferritin [Mass/volume] in Serum or Plasma 62 ng/mL (low)
Reference In heart failure, below 100 ng/mL, or 100 to 299 with transferrin saturation below 20%, is iron deficiency
http://loinc.org · 2276-4
S 1957-03-16 Iron saturation [Mass Fraction] in Serum or Plasma 16% (low)
Reference 20-50%
http://loinc.org · 2502-3
S 1957-03-16 Thyrotropin [Units/volume] in Serum or Plasma 2.1 mIU/L
Reference 0.45-4.5 mIU/L
http://loinc.org · 3016-3
S 1957-03-16 Hemoglobin A1c/Hemoglobin.total in Blood 5.9% (high)
Reference <=5.6%
http://loinc.org · 4548-4
S 1957-03-16 Cholesterol [Mass/volume] in Serum or Plasma 168 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1957-03-16 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 92 mg/dL (high)
Reference Secondary-prevention goal below 70 mg/dL
http://loinc.org · 13457-7
S 1957-03-16 Cholesterol in HDL [Mass/volume] in Serum or Plasma 44 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1957-03-16 Triglyceride [Mass/volume] in Serum or Plasma 160 mg/dL (high)
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1957-03-16 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 28 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1957-03-16 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 1957-03-16 Overall summary score [KCCQ-12] 38 http://loinc.org · 86924-8
S 1957-03-30 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1957-03-30 Potassium [Moles/volume] in Serum or Plasma 3.9 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1957-03-30 Creatinine [Mass/volume] in Serum or Plasma 1.08 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1957-03-30 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M 76 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1957-03-30 Glucose [Mass/volume] in Serum or Plasma 98 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1957-03-30 Magnesium [Mass/volume] in Serum or Plasma 1.9 mg/dL
Reference 1.6-2.6 mg/dL
http://loinc.org · 19123-9
S 1957-03-30 Left ventricular Ejection fraction 30% (low)
Reference 50-70%
http://loinc.org · 10230-1
S 1957-04-13 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1957-04-13 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1957-04-13 Creatinine [Mass/volume] in Serum or Plasma 1.16 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1957-04-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M 69 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1957-04-13 Glucose [Mass/volume] in Serum or Plasma 96 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1957-04-13 Magnesium [Mass/volume] in Serum or Plasma 2 mg/dL
Reference 1.6-2.6 mg/dL
http://loinc.org · 19123-9
S 1957-04-13 Overall summary score [KCCQ-12] 56 http://loinc.org · 86924-8
S 1957-04-22 Sodium [Moles/volume] in Serum or Plasma 133 mmol/L (low)
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1957-04-22 Potassium [Moles/volume] in Serum or Plasma 5.5 mmol/L (high)
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1957-04-22 Creatinine [Mass/volume] in Serum or Plasma 1.52 mg/dL (high)
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1957-04-22 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M 50 mL/min/1.73 m² (low)
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1957-04-22 Glucose [Mass/volume] in Serum or Plasma 88 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1957-04-22 Magnesium [Mass/volume] in Serum or Plasma 2.1 mg/dL
Reference 1.6-2.6 mg/dL
http://loinc.org · 19123-9
S 1957-04-27 Sodium [Moles/volume] in Serum or Plasma 137 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1957-04-27 Potassium [Moles/volume] in Serum or Plasma 4.8 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1957-04-27 Creatinine [Mass/volume] in Serum or Plasma 1.2 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1957-04-27 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M 67 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1957-04-27 Glucose [Mass/volume] in Serum or Plasma 97 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1957-04-27 Magnesium [Mass/volume] in Serum or Plasma 2 mg/dL
Reference 1.6-2.6 mg/dL
http://loinc.org · 19123-9
S 1957-04-27 Cholesterol [Mass/volume] in Serum or Plasma 130 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 1957-04-27 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 mg/dL
Reference Secondary-prevention goal below 70 mg/dL
http://loinc.org · 13457-7
S 1957-04-27 Cholesterol in HDL [Mass/volume] in Serum or Plasma 45 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 1957-04-27 Triglyceride [Mass/volume] in Serum or Plasma 115 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 1957-04-27 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 1957-04-27 Overall summary score [KCCQ-12] 66 http://loinc.org · 86924-8
S 1957-09-14 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 1957-09-28 Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma 620 pg/mL (high)
Reference Below 125 pg/mL makes heart failure unlikely outside the hospital
http://loinc.org · 33762-6
S 1957-09-28 Sodium [Moles/volume] in Serum or Plasma 138 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 1957-09-28 Potassium [Moles/volume] in Serum or Plasma 4.6 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 1957-09-28 Creatinine [Mass/volume] in Serum or Plasma 1.14 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 1957-09-28 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1952)/1.73 sq M 70 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 1957-09-28 Glucose [Mass/volume] in Serum or Plasma 95 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 1957-09-28 Magnesium [Mass/volume] in Serum or Plasma 2 mg/dL
Reference 1.6-2.6 mg/dL
http://loinc.org · 19123-9
S 1957-09-28 Hemoglobin [Mass/volume] in Blood 14.1 g/dL
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 1957-09-28 Ferritin [Mass/volume] in Serum or Plasma 248 ng/mL
Reference In heart failure, below 100 ng/mL, or 100 to 299 with transferrin saturation below 20%, is iron deficiency
http://loinc.org · 2276-4
S 1957-09-28 Iron saturation [Mass Fraction] in Serum or Plasma 27%
Reference 20-50%
http://loinc.org · 2502-3
S 1957-09-28 Left ventricular Ejection fraction 38% (low)
Reference 50-70%
http://loinc.org · 10230-1
S 1957-09-28 Overall summary score [KCCQ-12] 80 http://loinc.org · 86924-8
S 1957-09-14 Total score [Mini-Cog] 5 http://loinc.org · 72233-0
S 1957-09-14 Total score [AUDIT-C] 0 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
1957-03-16Body height185 cm8302-2S
1957-03-16Body weight97.6 kg29463-7S
1957-03-16Body mass index (BMI) [Ratio]28.5 kg/m239156-5S
1957-03-16Systolic blood pressure142 mm[Hg]8480-6S
1957-03-16Diastolic blood pressure86 mm[Hg]8462-4S
1957-03-16Heart rate92 /min8867-4S
1957-03-16Respiratory rate20 /min9279-1S
1957-03-16Body temperature36.7 Cel8310-5S
1957-03-16Oxygen saturation in Arterial blood by Pulse oximetry94 %59408-5S
1957-03-30Body height185 cm8302-2S
1957-03-30Body weight95 kg29463-7S
1957-03-30Body mass index (BMI) [Ratio]27.8 kg/m239156-5S
1957-03-30Systolic blood pressure134 mm[Hg]8480-6S
1957-03-30Diastolic blood pressure82 mm[Hg]8462-4S
1957-03-30Heart rate86 /min8867-4S
1957-03-30Respiratory rate18 /min9279-1S
1957-03-30Body temperature36.6 Cel8310-5S
1957-03-30Oxygen saturation in Arterial blood by Pulse oximetry96 %59408-5S
1957-04-13Body height185 cm8302-2S
1957-04-13Body weight93.6 kg29463-7S
1957-04-13Body mass index (BMI) [Ratio]27.3 kg/m239156-5S
1957-04-13Systolic blood pressure118 mm[Hg]8480-6S
1957-04-13Diastolic blood pressure72 mm[Hg]8462-4S
1957-04-13Heart rate74 /min8867-4S
1957-04-13Respiratory rate16 /min9279-1S
1957-04-13Body temperature36.6 Cel8310-5S
1957-04-13Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1957-04-27Body height185 cm8302-2S
1957-04-27Body weight93 kg29463-7S
1957-04-27Body mass index (BMI) [Ratio]27.2 kg/m239156-5S
1957-04-27Systolic blood pressure112 mm[Hg]8480-6S
1957-04-27Diastolic blood pressure70 mm[Hg]8462-4S
1957-04-27Heart rate68 /min8867-4S
1957-04-27Respiratory rate16 /min9279-1S
1957-04-27Body temperature36.6 Cel8310-5S
1957-04-27Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1957-09-28Body height185 cm8302-2S
1957-09-28Body weight92.8 kg29463-7S
1957-09-28Body mass index (BMI) [Ratio]27.1 kg/m239156-5S
1957-09-28Systolic blood pressure106 mm[Hg]8480-6S
1957-09-28Diastolic blood pressure66 mm[Hg]8462-4S
1957-09-28Heart rate64 /min8867-4S
1957-09-28Respiratory rate16 /min9279-1S
1957-09-28Body temperature36.5 Cel8310-5S
1957-09-28Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
1957-04-22Body height185 cm8302-2S
1957-04-22Body weight91.4 kg29463-7S
1957-04-22Body mass index (BMI) [Ratio]26.7 kg/m239156-5S
1957-04-22Systolic blood pressure102 mm[Hg]8480-6S
1957-04-22Diastolic blood pressure62 mm[Hg]8462-4S
1957-04-22Heart rate96 /min8867-4S
1957-04-22Respiratory rate16 /min9279-1S
1957-04-22Body temperature37.6 Cel8310-5S
1957-04-22Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
1957-09-14Body height185 cm8302-2S
1957-09-14Body weight92.6 kg29463-7S
1957-09-14Body mass index (BMI) [Ratio]27.1 kg/m239156-5S
1957-09-14Systolic blood pressure108 mm[Hg]8480-6S
1957-09-14Diastolic blood pressure68 mm[Hg]8462-4S
1957-09-14Heart rate64 /min8867-4S
1957-09-14Respiratory rate16 /min9279-1S
1957-09-14Body temperature36.6 Cel8310-5S
1957-09-14Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Euvolemia: no ankle swelling or orthopnea, with a steady dry weight1957-04-27completedDry weight about 93 kg; no edema or orthopnea; furosemide reduced to 20 mg
All four guideline-directed medicines at the highest doses he tolerates within three months1957-09-28activeAll four classes started within two weeks of diagnosis; carvedilol 12.5 mg twice daily, empagliflozin and spironolactone at their doses; sacubitril-valsartan stayed at the starting dose for five months after a missed titration step and was raised at six months
KCCQ-12 at least 20 points higher and NYHA class I to II within six months1957-09-28completedKCCQ-12 38 to 80; NYHA class I to II
Back in the ocean safely, swimming in calm water with a companion1957-09-28completedSwimming three mornings a week in calm water inside the reef with a friend, after cardiac rehabilitation
LDL cholesterol below 70 mg/dL1957-04-27completedLDL 62 mg/dL on atorvastatin 80 mg

Interventions

InterventionStatusGuideline
Culturally safe care: address him as Mr. Kahanamoku, as he asked; take time; explain each test and medicine plainly; involve his ʻohana as he chooses while he makes the decisionscompletedGL-KEOLAMAMO, GL-NH-HF-2015
Heart failure cardiology consultation on the day of the two-week visit, with an echocardiogram, to confirm the diagnosis and its cause and to plan guideline-directed medical therapy, ischemic evaluation and device decisionscompletedGL-HF-2022, GL-HFREF-ECDP-2024, GL-CMID-2026
Furosemide 40 mg every morning for congestion, with a daily weight and a written plan; metabolic panel and magnesium in one to two weeks; lower the dose when he is drycompletedGL-HF-2022, GL-CMID-2026
Baseline tests: ECG, chest X-ray, NT-proBNP, metabolic panel and magnesium, blood count, iron studies, TSH, hemoglobin A1c, lipids and ALT; echocardiogram at the two-week visitcompletedGL-HF-2022, GL-CMID-2026
Atorvastatin raised from 40 to 80 mg for LDL 92 mg/dL; lipid panel in four to twelve weeks; goal below 70 mg/dLcompletedGL-CCD-2023, GL-CMID-2026
Sodium: less salted and dried fish, shoyu and salty party food, using the foods he already eats; no routine fluid restriction; daily weightscompletedGL-HF-2022
Vaccinations: pneumococcal, influenza, COVID-19 and RSV as due, because heart disease raises the risk of severe respiratory infectioncompletedGL-HF-2022, GL-CDC-IMZ-2026
Native Hawaiian healing alongside clinic care, if he wishes: lomilomi through Ke Ola Mamo, a Native Hawaiian Health Care System; he will tell the clinic before using any plant medicine so that interactions can be checked; the clinic asks nothing further about his practicescompletedGL-KEOLAMAMO
Guideline-directed medical therapy: stop lisinopril and start sacubitril-valsartan 24/26 mg twice daily 36 hours after the last dose; change metoprolol tartrate to carvedilol 3.125 mg twice daily; empagliflozin 10 mg daily; add spironolactone when potassium and kidney function allow; raise one medicine every two weeks toward target doses, with a metabolic panel one to two weeks after each changecompletedGL-HF-2022, GL-HFREF-ECDP-2024, GL-CMID-2026
Intravenous ferric carboxymaltose 750 mg at the two-week visit and again two weeks later, for iron deficiency in heart failure with reduced ejection fraction; iron studies again at about six monthscompletedGL-HF-2022, GL-CMID-2026
Invasive coronary angiography within two weeks to define the coronary disease and whether revascularization could helpcompletedGL-HF-2022, GL-CCD-2023
Defibrillator decision: repeat echocardiogram after at least 90 days of optimized therapy; a primary-prevention ICD if the ejection fraction stays at 35% or below with NYHA class II to IIIcompletedGL-HF-2022, GL-VA-ICD-2017, GL-CMID-2026
Sick-day rules: on days of vomiting, diarrhea or not drinking, hold empagliflozin, furosemide, spironolactone and sacubitril-valsartan, keep carvedilol if blood pressure allows, drink small amounts often, and restart when eating and drinking normally for a day; a written cardcompletedGL-HF-2022, GL-HFREF-ECDP-2024
Cardiac rehabilitation for heart failure, 36 sessions, adapted to an ocean athlete: pool swimming in the program, then calm water inside the reef with a companion and near a lifeguard, no breath-hold diving, no big surf until cleared, water through the morning, and out of the water at once for chest pain, lightheadedness or unusual breathlessnesscompletedGL-HF-2022, GL-CMID-2026
Laboratory tests drawn at the clinic on the day of each medicine change or by the clinic's nurse at home, with nurse calls to titrate doses between visitscompletedGL-HFREF-ECDP-2024, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Duke Kahanamoku: biography and life timeline. American Masters PBS (WNET) other
SRC-0002 Luis C. A wonderful life (Duke Kahanamoku timeline). Honolulu Star-Advertiser, January 22, 2018 Honolulu Star-Advertiser other
SRC-0003 Luis C. Legacy of Hawaii's most beloved, honored athlete endures 50 years after his death. Honolulu Star-Advertiser, January 22, 2018 Honolulu Star-Advertiser other
SRC-0004 Duke Kahanamoku (athlete profile) Olympedia (OlyMADMen) other
SRC-0005 Duke Kahanamoku. Research Starters: History EBSCO biography
SRC-0006 August 24: celebrate the birth of one of Hawaii's greatest sons and 1965 ISHOF Honoree, Duke Kahanamoku International Swimming Hall of Fame other
SRC-0007 Kahanamoku, Duke. Encyclopedia of World Biography Gale, via Encyclopedia.com biography
SRC-0010 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the 36-hour washout from lisinopril to sacubitril-valsartan, the change from metoprolol tartrate to carvedilol, the order of titration, spironolactone with an eGFR above 30 and potassium below 5.0, the sick-day holds when potassium reached 5.5, the missed laboratory check after the last dose increases, intravenous iron at a ferritin of 62, angiography without revascularization, the decision against an ICD at an ejection fraction of 38%, and the ocean-safety plan.
provenance reviewnot_startedSources: PBS American Masters, two Honolulu Star-Advertiser articles of 2018, Olympedia, EBSCO, the International Swimming Hall of Fame and the Encyclopedia of World Biography. The Hawaiʻi State Archives, the Bishop Museum, olympics.com, the New York Times obituary and David Davis's biography Waterman were not read; a 1962 wire report found through Papers Past could not be fetched. The heart attack is dated 1952, not 1955.
safe messaging reviewnot_startedHis Native Hawaiian identity is described as he would describe it, without stereotype; his own healing practices are respected and not described. Mood screening is synthetic and negative. His wife appears only in a documented claim, and no relative or other real person is given a modern statement, decision or health fact.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.